Black Patients Less Likely to Fill Prescriptions For Newer, Safer Urinary Incontinence Drugs
A new study in JAMA Network Open led by Northwestern Medicine and Duke University School of Medicine shows Black patients are less likely to fill prescriptions for newer, safer urinary incontinence drugs compared to white patients, potentially raising their risk for dementia.
EDI Spotlight: Sharena Ballard-Hart
Sharena Ballard-Hart is the Senior Program Coordinator and HR Manager for the Brain Imaging and Analysis Center (BIAC). She also serves as the Equity, Diversity, and Inclusion (EDI) Leader for BIAC.
Creating Community for Asian American Students
Medical students Lily Guo and Linda Li each had different experiences before coming to Duke, but an affinity group for Asian American students gave them both a sense of belonging that they said they could not have found elsewhere.
Duke’s chapter of the Asian Pacific American Medical Student Association (APAMSA) is a student-run organization aimed at fostering a sense of community among the Asian American and Pacific Islander (AAPI) student population at Duke University School of Medicine.
Chantell Evans Named a HHMI Freeman Hrabowski Scholar
Chantell Evans is one of 31 inaugural recipients of the Howard Hughes Medical Institute's Freeman Hrabowsky Scholarships, a new award of up to $8.6M over 10 years for outstanding early career faculty dedicated to EDI.
EDI Spotlight: Sonali Biswas, MPHS
In her Spotlight interview, Sonali Biswas reflects on how connecting with students sharing her identities helped her overcome her imposter syndrome and feelings of isolation.
Dean Klotman's Friday Message & Conversation with Julius Wilder, MD, PhD
Dean Klotman welcomes Julius Wilder, MD, PhD, Assistant Professor of Medicine, and Assistant Professor of Sociology, to discuss the rising rate of colon cancer in young adults, and what Duke is doing to help turn this trend around.
Study Examines Reluctance of Black Patients to Get Defibrillators
Black patients at risk for sudden cardiac arrest have historically been less likely to receive potentially life-saving implantable cardioverter defibrillators (ICD) than white patients.